Literature DB >> 181532

Temperature-sensitive mutants of herpes simplex virus type 2: description of three new complementation groups and studies on the inhibition of host cell DNA synthesis.

I W Halliburton, M C Timbury.   

Abstract

Three new complementation groups of type 2 herpes simplex virus are described bringing the total number of complementation groups characterized to 13. Of the three new groups, ts 11 fails to make virus DNA at non-permissive temperature (38 degrees C) whereas ts 12 and ts 13 synthesize only very small amounts of virus or cellular DNA at 38 degrees C. ts 11, like ts 9 (Halliburton & Timbury, 1973) fails to switch off host cell DNA synthesis at 38 degrees C. That this is a failure to switch off cell DNA rather than a stimulation of cell DNA synthesis was confirmed in experiments using resting cells. Both the inability to make virus DNA and the inability to switch off cell DNA are reversed in temperature shift-down experiments with cells infected with ts 9 or ts 11. In temperature shift-up experiments, cellular DNA synthesis is inhibited after the shift but virus DNA is only made in very small amounts, probably due to the continuing functioning of a protein made at permissive temperature (31 degrees C) before the shift but which cannot be made at 38 degrees C. The shift-down experiments and the fact that ts 9 and ts 11 complement one another, suggest that the switch-off of host cell DNA synthesis may involve more than one virus specified function. U.v. irradiated virus fails to switch off host cell DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181532     DOI: 10.1099/0022-1317-30-2-207

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Physical mapping of herpes simplex virus-induced polypeptides.

Authors:  H S Marsden; N D Stow; V G Preston; M C Timbury; N M Wilkie
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

2.  Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Authors:  P A Schaffer; V C Carter; M C Timbury
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

3.  Characterization of a continuous smooth muscle cell line derived from rabbit aorta.

Authors:  M Nachtigal; M L Nagpal; P Greenspan; S A Nachtigal; A Legrand
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

4.  Collaborative study of temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  M C Timbury; M L Hendricks; P A Schaffer
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

5.  Mutant of herpes simplex virus type 2 with temperature-sensitive lesions affecting virion thermostability and DNase activity: identification of the lethal mutation and physical mapping of the nuc-lesion.

Authors:  P Chartrand; M C Timbury; J Hay; H Moss
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

6.  Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.

Authors:  T W North; S S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.

Authors:  K E Schneweis; H Forstbauer; M Olbrich; M Tag
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

8.  Inactivation of herpes simplex virus by a pregnene derivative (TX 3047).

Authors:  B Perbal
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

9.  Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.

Authors:  V G Preston; J A Coates; F J Rixon
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  Isolation and preliminary characterization of a phosphonoacetic acid-resistant and temperature-sensitive mutant of herpes simplex virus type 1.

Authors:  J I Daksis; M M Priemer; V L Chan
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.